Works by LaPlant, Betsy

Results: 43

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

Published in:

Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477

By:

Ailawadhi, Sikander;
Parrondo, Ricardo D.;
Dutta, Navnita;
Han, Bing;
Ciccio, Gina;
Cherukuri, Yesesri;
Alegria, Victoria R.;
LaPlant, Betsy R.;
Roy, Vivek;
Sher, Taimur;
Edwards, Brett;
Lanier, Stephanie;
Manna, Alak;
Heslop, Keisha;
Caulfield, Thomas;
Maldosevic, Emir;
Storz, Peter;
Manochakian, Rami;
Asmann, Yan;
Chanan-Khan, Asher A.

Publication type:

Article

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x

By:

Desai, Sanjal H.;
Pederson, Levi;
LaPlant, Betsy;
Mwangi, Raphael;
Maurer, Matthew;
Young, Jason R.;
Macon, William R.;
King, Rebecca L.;
Wang, Yucai;
Cerhan, James R.;
Feldman, Andrew;
Inwards, David J.;
Micallef, Ivana;
Johnston, Patrick;
Porrata, Luis F.;
Ansell, Stephen M.;
Habermann, Thomas M.;
Witzig, Thomas E.;
Nowakowski, Grzegorz S.

Publication type:

Article

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z

By:

Desai, Sanjal H.;
LaPlant, Betsy;
Macon, William R.;
King, Rebecca L.;
Wang, Yucai;
Inwards, David J.;
Micallef, Ivana;
Johnston, Patrick B.;
Porrata, Luis F.;
Ansell, Stephen M.;
Habermann, Thomas M.;
Witzig, Thomas E.;
Nowakowski, Grzegorz S.

Publication type:

Article

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis.

Published in:

Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0266-9

By:

Warsame, Rahma;
LaPlant, Betsy;
Kumar, Shaji K.;
Laumann, Kristina;
Perez Burbano, Gabriela;
Buadi, Francis K.;
Gertz, Morie A.;
Kyle, Robert A.;
Lacy, Martha Q.;
Dingli, David;
Leung, Nelson;
Hayman, Suzanne R.;
Kapoor, Prashant;
Hwa, Yi L.;
Fonder, Amie;
Hobbs, Miriam;
Gonsalves, Wilson I.;
Kourelis, Taxiarchis;
Lust, John;
Russell, Stephen J.

Publication type:

Article

Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors.

Published in:

2021

By:

Hwang, Steven R.;
Higgins, Alexandra;
Castillo Almeida, Natalia E.;
LaPlant, Betsy;
Maurer, Matthew J.;
Ansell, Stephen M.;
Witzig, Thomas E.;
Thanarajasingam, Gita;
Bennani, N. Nora

Publication type:

Letter

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study.

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 7, p. 1585, doi. 10.3109/10428194.2015.1113280

By:

Zent, Clive S.;
Bowen, Deborah A.;
Conte, Michael J.;
LaPlant, Betsy R.;
Call, Timothy G.

Publication type:

Article

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 8, p. 2373, doi. 10.3109/10428194.2015.1016932

By:

Zent, Clive S.;
Call, Timothy G.;
Bowen, Deborah A.;
Conte, Michael J.;
LaPlant, Betsy R.;
Witzig, Thomas E.;
Ansell, Stephen M.;
Weiner, George J.

Publication type:

Article

A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 2061, doi. 10.3109/10428194.2014.977886

By:

Mattison, Ryan;
Jumonville, Alcee;
Flynn, Patrick James;
Moreno-Aspitia, Alvaro;
Erlichman, Charles;
LaPlant, Betsy;
Juckett, Mark B.

Publication type:

Article

Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.

Published in:

American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125

By:

Wudhikarn, Kitsada;
Padrnos, Leslie;
Lasho, Terra;
LaPlant, Betsy;
Kumar, Shaji;
Dispenzieri, Angela;
Lacy, Martha;
Rajkumar, S. Vincent;
Gertz, Morie;
Mangaonkar, Abhishek A.;
Gonsalves, Wilson;
Ketterling, Rhett;
Shi, Chang‐Xin;
Fonseca, Rafael;
Stewart, A. Keith;
Patnaik, Mrinal M.

Publication type:

Article

Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma.

Published in:

American Journal of Hematology, 2019, v. 94, n. 7, p. 786, doi. 10.1002/ajh.25493

By:

St‐Pierre, Frédérique;
Broski, Stephen M.;
LaPlant, Betsy R.;
Ristow, Kay;
Maurer, Matthew J.;
Macon, William R.;
Habermann, Thomas M.;
Ansell, Stephen M.;
Thompson, Carrie A.;
Micallef, Ivana N. M.;
Nowakowski, Grzegorz S.;
Witzig, Thomas E.

Publication type:

Article

<italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.

Published in:

American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955

By:

Abeykoon, Jithma P.;
Paludo, Jonas;
King, Rebecca L.;
Ansell, Stephen M.;
Gertz, Morie A.;
LaPlant, Betsy R.;
Halvorson, Alese E.;
Gonsalves, Wilson I.;
Dingli, David;
Fang, Hong;
Rajkumar, S. Vincent;
Lacy, Martha Q.;
He, Rong;
Kourelis, Taxiarchis;
Reeder, Craig B.;
Novak, Anne J.;
McPhail, Ellen D.;
Viswanatha, David S.;
Witzig, Thomas E.;
Go, Ronald S.

Publication type:

Article

Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)

Published in:

American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824

By:

Witzig, Thomas E.;
Johnston, Patrick B.;
LaPlant, Betsy R.;
Kurtin, Paul J.;
Pederson, Levi D.;
Moore Jr, Dennis F.;
Nabbout, Nassim H.;
Nikcevich, Daniel A.;
Rowland, Kendrith M.;
Grothey, Axel

Publication type:

Article

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

Published in:

American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762

By:

Larsen, Jeremy T.;
Shanafelt, Tait D.;
Leis, Jose F.;
LaPlant, Betsy;
Call, Tim;
Pettinger, Adam;
Hanson, Curtis;
Erlichman, Charles;
Habermann, Thomas Matthew;
Reeder, Craig;
Nikcevich, Daniel;
Bowen, Deborah;
Conte, Michael;
Boysen, Justin;
Secreto, Charla;
Lesnick, Connie;
Tschumper, Renee;
Jelinek, Diane;
Kay, Neil E.;
Ding, Wei

Publication type:

Article

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

Published in:

American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671

By:

Bennani, N. Nora;
LaPlant, Betsy R.;
Ansell, Stephen M.;
Habermann, Thomas. M.;
Inwards, David J.;
Micallef, Ivana N.;
Johnston, Patrick B.;
Porrata, Luis F.;
Colgan, Joseph P.;
Markovic, Svetomir N.;
Nowakowski, Grzegorz S.;
Macon, William R.;
Reeder, Craig B.;
Mikhael, Joseph R.;
Northfelt, Donald W.;
Ghobrial, Irene M.;
Witzig, Thomas E.

Publication type:

Article

Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.

Published in:

American Journal of Hematology, 2015, v. 90, n. 12, p. 1106, doi. 10.1002/ajh.24181

By:

Kumar, Shaji K.;
Krishnan, Amrita;
LaPlant, Betsy;
Laumann, Kristina;
Roy, Vivek;
Zimmerman, Todd;
Gertz, Morie A.;
Buadi, Francis K.;
Goldstein, Keith Stockerl;
Birgin, Ann;
Fiala, Mark;
Duarte, Lupe;
Maharaj, Michelle;
Levy, Joan;
Vij, Ravi

Publication type:

Article

Elevated soluble IL-2 Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.

Published in:

American Journal of Hematology, 2014, v. 89, n. 12, p. E223, doi. 10.1002/ajh.23838

By:

Sonbol, Mohamad B.;
Maurer, Matthew J.;
Stenson, Mary J.;
Allmer, Cristine;
LaPlant, Betsy R.;
Weiner, George J.;
Macon, William R.;
Cerhan, James R.;
Witzig, Thomas E.;
Gupta, Mamta

Publication type:

Article

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

Published in:

American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737

By:

Zent, Clive S.;
Taylor, Ronald P.;
Lindorfer, Margaret A.;
Beum, Paul V.;
LaPlant, Betsy;
Wu, Wenting;
Call, Timothy G.;
Bowen, Deborah A.;
Conte, Michael J.;
Frederick, Lori A.;
Link, Brian K.;
Blackwell, Sue E.;
Veeramani, Suresh;
Baig, Nisar A.;
Viswanatha, David S.;
Weiner, George J.;
Witzig, Thomas E.

Publication type:

Article

Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.

Published in:

American Journal of Hematology, 2014, v. 89, n. 3, p. 237, doi. 10.1002/ajh.23620

By:

Ghobrial, Irene M.;
Witzig, Thomas E.;
Gertz, Morie;
LaPlant, Betsy;
Hayman, Suzanne;
Camoriano, John;
Lacy, Martha;
Bergsagel, P. Leif;
Chuma, Stacey;
DeAngelo, Daniel;
Treon, Steven P.

Publication type:

Article

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.

Published in:

American Journal of Hematology, 2010, v. 85, n. 5, p. 320, doi. 10.1002/ajh.21664

By:

Johnston, Patrick B.;
Inwards, David J.;
Colgan, Joseph P.;
Laplant, Betsy R.;
Kabat, Brian F.;
Habermann, Thomas M.;
Micallef, Ivana N.;
Porrata, Luis F.;
Ansell, Stephen M.;
Reeder, Craig B.;
Roy, Vivek;
Witzig, Thomas E.

Publication type:

Article

Complementary and alternative medicine use among long-term lymphoma survivors: A pilot study.

Published in:

American Journal of Hematology, 2009, v. 84, n. 12, p. 795, doi. 10.1002/ajh.21554

By:

Habermann, Thomas M.;
Thompson, Carrie A.;
LaPlant, Betsy R.;
Bauer, Brent A.;
Janney, Carol A.;
Clark, Matthew M.;
Rummans, Teresa A.;
Maurer, Matthew J.;
Sloan, Jeff A.;
Geyer, Susan M.;
Cerhan, James R.

Publication type:

Article

Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma.

Published in:

American Journal of Hematology, 2009, v. 84, n. 2, p. 71, doi. 10.1002/ajh.21328

By:

Ansell, Stephen M.;
Novak, Anne J.;
Ziesmer, Steven;
Price-Troska, Tammy;
LaPlant, Betsy;
Dillon, Stacey R.;
Witzig, Thomas E.

Publication type:

Article

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma.

Published in:

2024

By:

Parrondo, Ricardo D.;
LaPlant, Betsy R.;
Elliott, Jamie;
Fernandez, Andre;
Flott, Caitlin J.;
Arrington, Diedre;
Chapin, Dustin;
Brown, Jade;
Das, Saurav;
Roy, Vivek;
Chanan-Khan, Asher A.;
Ailawadhi, Sikander

Publication type:

Letter

Pilot study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with POEMS Syndrome.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e311, doi. 10.1016/j.clml.2019.09.512

By:

Dispenzieri, Angela;
Lacy, Martha;
Mauermann, Michelle;
LaPlant, Betsy;
Go, Ronald;
Kapoor, Prashant;
Hwa, Yi Lisa;
Fonder, Amie;
Hobbs, Miriam;
Buadi, Francis;
Hayman, Suzanne;
Leung, Nelson;
Lust, John;
Dingli, David;
Gonsalves, Wilson;
Kourelis, Taxiarchis;
Warsame, Rahma;
Rajkumar, S.Vincent;
Kumar, Shaji;
Gertz, Morie A.

Publication type:

Article

Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia.

Published in:

Expert Review of Hematology, 2018, v. 11, n. 4, p. 337, doi. 10.1080/17474086.2018.1442716

By:

Kay, Neil E.;
LaPlant, Betsy R.;
Pettinger, Adam M.;
Call, Timothy G.;
Leis, Jose F.;
Ding, Wei;
Parikh, Sameer A.;
Conte, Michael J.;
Bowen, Deborah A.;
Shanafelt, Tait D.

Publication type:

Article

A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.

Published in:

British Journal of Haematology, 2024, v. 204, n. 5, p. 1825, doi. 10.1111/bjh.19320

By:

Parrondo, Ricardo D.;
Dutta, Navnita;
LaPlant, Betsy R.;
Elliott, Jamie;
Fernandez, Andre;
Zimmerman, Ashley;
Cicco, Gina;
Han, Bing;
Heslop, Keisha;
Chapin, Dustin;
Sher, Taimur;
Roy, Vivek;
Rasheed, Ahsan;
Das, Saurav;
Chanan‐Khan, Asher A.;
Paulus, Aneel;
Ailawadhi, Sikander

Publication type:

Article

Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS).

Published in:

Annals of Hematology, 2012, v. 91, n. 1, p. 33, doi. 10.1007/s00277-011-1240-1

By:

Cashen, Amanda;
Juckett, Mark;
Jumonville, Alcee;
Litzow, Mark;
Flynn, P.;
Eckardt, John;
LaPlant, Betsy;
Laumann, Kristina;
Erlichman, Charles;
DiPersio, John

Publication type:

Article

Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.

Published in:

Hematological Oncology, 2022, v. 40, n. 4, p. 695, doi. 10.1002/hon.3012

By:

Ailawadhi, Sikander;
Parrondo, Ricardo D.;
Moustafa, Muhamad Alhaj;
LaPlant, Betsy R.;
Alegria, Victoria;
Chapin, Dustin;
Roy, Vivek;
Sher, Taimur;
Paulus, Aneel;
Chanan‐Khan, Asher A.

Publication type:

Article

Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL).

Published in:

Cancer (0008543X), 2013, v. 119, n. 21, p. 3788, doi. 10.1002/cncr.28292

By:

Shanafelt, Tait;
Lanasa, Mark C.;
Call, Timothy G.;
Beaven, Anne W.;
Leis, Jose F.;
LaPlant, Betsy;
Bowen, Deborah;
Conte, Michael;
Jelinek, Diane F.;
Hanson, Curtis A.;
Kay, Neil E.;
Zent, Clive S.

Publication type:

Article

Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.

Published in:

Cancer (0008543X), 2013, v. 119, n. 2, p. 363, doi. 10.1002/cncr.27719

By:

Shanafelt, Tait D.;
Call, Timothy G.;
Zent, Clive S.;
Leis, Jose F.;
LaPlant, Betsy;
Bowen, Deborah A.;
Roos, Michelle;
Laumann, Kristina;
Ghosh, Asish K.;
Lesnick, Connie;
Lee, Mao-Jung;
Yang, Chung S.;
Jelinek, Diane F.;
Erlichman, Charles;
Kay, Neil E.

Publication type:

Article

Bone involvement on PET/CT predicts event‐free survival in follicular lymphoma Grade 3B.

Published in:

British Journal of Haematology, 2020, v. 191, n. 2, p. e41, doi. 10.1111/bjh.16974

By:

St‐Pierre, Frederique;
Broski, Stephen M.;
LaPlant, Betsy R.;
Ristow, Kay;
Macon, William R.;
Habermann, Thomas M.;
Witzig, Thomas E.

Publication type:

Article

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.

Published in:

2016

By:

Crozier, Jennifer A.;
Advani, Pooja P.;
LaPlant, Betsy;
Hobday, Timothy;
Jaslowski, Anthony J.;
Moreno-Aspitia, Alvaro;
Perez, Edith A.

Publication type:

journal article

The Treatment of Recurrent/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Everolimus Results in Clinical Responses and Mobilization of CLL Cells Into the Circulation.

Published in:

Cancer (0008543X), 2010, v. 116, n. 9, p. 2201, doi. 10.1002/cncr.25005

By:

Zent, Clive S.;
LaPlant, Betsy R.;
Johnston, Patrick B.;
Call, Timothy G.;
Habermann, Thomas M.;
Micallef, Ivana N.;
Witzig, Thomas E.

Publication type:

Article

Pentostatin and Rituximab Therapy for Previously Untreated Patients With B-Cell Chronic Lymphocytic Leukemia.

Published in:

Cancer (0008543X), 2010, v. 116, n. 9, p. 2180, doi. 10.1002/cncr.25028

By:

Kay, Neil E.;
Wenting Wu;
Kabat, Brian;
LaPlant, Betsy;
Lin, Thomas S.;
Byrd, John C.;
Jelinek, Diane F.;
Grever, Michael R.;
Zent, Clive S.;
Call, Timothy G.;
Shanafelt, Tait D.

Publication type:

Article

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.

Published in:

2008

By:

Zent, Clive S.;
Call, Timothy G.;
Shanatelt, Tait D.;
Tschumper, Renee C.;
Jelinek, Diane F.;
Bowen, Deborah A.;
Secreto, Charla R.;
LaPlant, Betsy R.;
Kabat, Brian F.;
Kay, Neil E.;
Shanafelt, Tait D

Publication type:

journal article

Fluorodeoxyglucose‐Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.

Published in:

Oncologist, 2020, v. 25, n. 8, p. 689, doi. 10.1634/theoncologist.2019-0952

By:

St‐Pierre, Frédérique;
Broski, Stephen M.;
LaPlant, Betsy R.;
Maurer, Matthew J.;
Ristow, Kay;
Thanarajasingam, Gita;
Macon, William R.;
Habermann, Thomas M.;
Witzig, Thomas E.

Publication type:

Article

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study.

Published in:

Cancer (0008543X), 2025, v. 131, n. 4, p. 1, doi. 10.1002/cncr.35750

By:

Luskin, Marlise R.;
Yin, Jun;
Lozanski, Gerard;
Curran, Emily;
Malnassy, Gregory;
Mrózek, Krzysztof;
Bloomfield, Clara D.;
Cataland, Spero R.;
Fulton, Noreen;
Kolitz, Jonathan;
Laplant, Betsy;
Kour, Oudom;
Powell, Bayard L.;
Vij, Ravi;
Wang, Eunice S.;
Grinblatt, David;
Stone, Richard M.;
Uy, Geoffrey L.;
Larson, Richard A.;
Stock, Wendy

Publication type:

Article

Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 11, p. 2218, doi. 10.3109/10428194.2012.681657

By:

Baig, Nisar A.;
Taylor, Ronald P.;
Lindorfer, Margaret A.;
Church, Amy K.;
Laplant, Betsy R.;
Pavey, Emily S.;
Nowakowski, Grzegorz S.;
Zent, Clive S.

Publication type:

Article

Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 12, p. 2222, doi. 10.3109/10428194.2010.524327

By:

Shanafelt, Tait;
Zent, Clive;
Byrd, John;
Erlichman, Charles;
Laplant, Betsy;
Ghosh, Asish;
Call, Timothy;
Villalona-Calero, Miguel;
Jelinek, Diane;
Bowen, Deborah;
Laumann, Kristina;
Wu, Wenting;
Hanson, Curtis;
Kay, Neil

Publication type:

Article

N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia.

Published in:

Leukemia & Lymphoma, 2009, v. 50, n. 4, p. 588, doi. 10.1080/10428190902777467

By:

Kay, Neil E.;
Shanafelt, Tait D.;
Call, Timothy G.;
Wu, Wenting;
Laplant, Betsy R.

Publication type:

Article

Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group.

Published in:

Leukemia & Lymphoma, 2008, v. 49, n. 6, p. 1074, doi. 10.1080/10428190801993470

By:

Witzig, Thomas E.;
Geyer, Susan M.;
Kurtin, Paul J.;
Colgan, Joseph P.;
Inwards, David J.;
Micallef, Ivana N. M.;
LaPlant, Betsy R.;
Michalak, John C.;
Salim, Muhammad;
Dalton, Robert J.;
Moore, Dennis F.;
Reeder, Craig B.

Publication type:

Article

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2009, v. 146, n. 6, p. 660, doi. 10.1111/j.1365-2141.2009.07811.x

By:

Shanafelt, Tait D.;
Byrd, John C.;
LaPlant, Betsy;
Zent, Clive S.;
Call, Tim;
Secreto, Charla;
Grever, Michael R.;
Lin, Thomas S.;
Kay, Neil E.

Publication type:

Article

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2008, v. 141, n. 5, p. 607, doi. 10.1111/j.1365-2141.2008.07070.x

By:

Palmer, Shanique;
Hanson, Curtis A.;
Zent, Clive S.;
Porrata, Luis F.;
LaPlant, Betsy;
Geyer, Susan M.;
Markovic, Svetomir N.;
Call, Timothy G.;
Bowen, Deborah A.;
Jelinek, Diane F.;
Kay, Neil E.;
Shanafelt, Tait D.

Publication type:

Article

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Published in:

British Journal of Haematology, 2008, v. 140, n. 5, p. 537, doi. 10.1111/j.1365-2141.2007.06965.x

By:

Shanafelt, Tait D.;
Geyer, Susan M.;
Bone, Nancy D.;
Tschumper, Renee C.;
Witzig, Tom E.;
Nowakowski, Greg S.;
Zent, Clive S.;
Call, Tim G.;
LaPlant, Betsy;
Dewald, Gordon W.;
Jelinek, Diane F.;
Kay, Neil E.

Publication type:

Article